Lysophosphatidic acid modulates the activation of human monocyte-derived dendritic cells

Stem Cells and Development

Volumn 15, Issue 6, 2006, Pages 797-804

  Chen, Rongbing ^a   Roman, Jessica ^a   Guo, Jia ^b   West, Erin ^a   McDyer, John ^a   Williams, Marc A ^b   Georas, Steve N ^b  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LYSOPHOSPHATIDIC ACID;

ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL POLARITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; COCULTURE TECHNIQUES; CONSERVED SEQUENCE; CYTOKINES; DENDRITIC CELLS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYSOPHOSPHOLIPIDS; MICE; MOLECULAR SEQUENCE DATA; MONOCYTES; RECEPTORS, LYSOPHOSPHATIDIC ACID; T-LYMPHOCYTES;

EID: 33846448731     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.15.797     Document Type: Article

References (29)

1. Goetzl EJ and H Rosen. (2004). Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J Clin Invest 114:1531-1537.
2. Hla T, MJ Lee, N Ancellin, JH Paik and MJ Kluk. (2001). Lysophospholipids-receptor revelations. Science 294:1875-1878.
3. Fukushima N and J Chun. (2001). The LPA receptors. Prostaglandins Other Lipid Mediat 64:21-32.
4. Ye X, K Hama, JJ Contos, B Anliker, A Inoue, MK Skinner, H Suzuki, T Amano, G Kennedy, H Arai, J Aoki and J Chun. (2005). LPA3-mediated lysophosphatidic acid signaling in embryo implantation and spacing. Nature 435:104-108.
5. Contos JJ, I Ishii, N Fukushima, MA Kingsbury, X Ye, S Kawamura, JH Brown and J Chun. (2002). Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol 22:6921-6929.
6. Valet P, C Pages, O Jeanneton, D Daviaud, P Barbe, M Record, JS Saulnier-Blache and M Lafontan. (1998). Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J Clin Invest 101:1431-1438.
7. Lee H, EJ Goetzl and S An. (2000). Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol 278:C612-C618.
8. Goetzl EJ. (2001). Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids. Prostaglandins Other Lipid Mediat 64:11-20.
9. Sautin YY, JM Crawford and SI Svetlov. (2001). Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line. Am J Physiol Cell Physiol 281:C2010-C2019.
10. Deng W, DA Wang, E Gosmanova, LR Johnson and G Tigyi. (2003). LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway. Am J Physiol Gastrointest Liver Physiol 284:G821-G829.
11. Zhang C, DL Baker, S Yasuda, N Makarova, L Balazs, LR Johnson, GK Marathe, TM McIntyre, Y Xu, GD Prestwich, HS Byun, R Bittman and G Tigyi. (2004). Lysophosphatidic acid induces neointima formation through PPAR gamma activation. J Exp Med 199:763-774.
12. Sayas CL, MT Moreno-Flores, J Avila and F Wandosell. (1999). The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation. J Biol Chem 274:37046-37052.
13. Inoue M, MH Rashid, R Fujita, JJ Contos, J Chun and H Ueda. (2004). Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nature Med 10:712-718.
14. Goetzl EJ, Y Kong and B Mei. (1999). Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J Immunol 162:2049-2056.
15. Goetzl EJ, Y Kong and JK Voice. (2000). Cutting edge: differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. J Immunol 164:4996-4999.
16. Zheng Y, JK Voice, Y Kong and EJ Goetzl. (2000). Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes. FASEB J 14:2387-2389.
17. Zheng Y, Y Kong and EJ Goetzl. (2001). Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane. J Immunol 166:2317-2322.
18. Georas SN. (2004). Inhaled glucocorticoids, lymphocytes, and dendritic cells in asthma and obstructive lung diseases. Proc Am Thorac Soc 1:215-221.
19. Rubenfeld J, J Guo, N Sookrung, R Chen, W Chaicumpa, V Casolaro, Y Zhao, V Natarajan and S Georas. (2006). Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells. Am J Physiol Lung Cell Mol Physiol 290:L66-L74.
20. Panther E, M Idzko, S Corinti, D Ferrari, Y Herouy, M Mockenhaupt, S Dichmann, P Gebicke-Haerter, F Di Virgilio, G Girolomoni and J Norgauer. (2002). The influence of lysophosphatidic acid on the functions of human dendritic cells. J Immunol 169:4129-4135.
21. Georas SN, MC Liu, W Newman, LD Beall, BA Stealey and BS Bochner. (1992). Altered adhesion molecule expression and endothelial cell activation accompany the recruitment of human granulocytes to the lung after segmental antigen challenge. Am J Respir Cell Mol Biol 7:261-269.
22. Panther E, S Corinti, M Idzko, Y Herouy, M Napp, A La Sala, G Girolomoni and J Norgauer. (2003). Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 101:3985-3990.
23. + T cell-mediated suppression by dendritic cells. Science 299:1033-1036.
24. Akbari O, RH DeKruyff and DT Umetsu. (2001). Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol 2:725-731.
25. Eisenbarth SC, DA Piggott, JW Huleatt, I Visintin, CA Herrick and K Bottomly. (2002). Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196:1645-1651.
26. Chauveau C, S Remy, PJ Royer, M Hill, S Tanguy-Royer, FX Hubert, L Tesson, R Brion, G Beriou, M Gregoire, R Josien, MC Cuturi and I Anegon. (2005). Heme oxygenase-1 expression inhibits dendritic cell maturation and pro-inflammatory function but conserves IL-10 expression. Blood 106:1694-1702.
27. Faith A, J McDonald, E Peek, D Richards, J Caulfield, E Chevretton, D Roberts, T Lee, C Corrigan and C Hawrylowicz. (2005). Functional plasticity of human respiratory tract dendritic cells: GM-CSF enhances T(H)2 development. J Allergy Clin Immunol 116:1136-1143.
28. Huang MC, M Graeler, G Shankar, J Spencer and EJ Goetzl. (2002). Lysophospholipid mediators of immunity and neoplasia. Biochim Biophys Acta 1582:161-167.
29. Dodge IL, MW Carr, M Cernadas and MB Brenner. (2003). IL-6 production by pulmonary dendritic cells impedes ThI immune responses. J Immunol 170:4457-4464.